Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
35,163,514
-
Share change
-
-127,660
-
Total reported value
-
$1,305,816,189
-
Put/Call ratio
-
30%
-
Price per share
-
$37.13
-
Number of holders
-
261
-
Value change
-
-$16,188,647
-
Number of buys
-
111
-
Number of sells
-
147
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2024
As of 31 Dec 2024,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
261 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,163,514 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TD ASSET MANAGEMENT INC, STATE STREET CORP, NEUBERGER BERMAN GROUP LLC, Pacer Advisors, Inc., DIMENSIONAL FUND ADVISORS LP, FULLER & THALER ASSET MANAGEMENT, INC., Epoch Investment Partners, Inc., and Boston Trust Walden Corp.
This page lists
261
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.